Overview

Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the electrocardiogram (ECG) effects of Sancuso® compared to placebo and moxifloxacin in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Prostrakan Pharmaceuticals
Treatments:
Fluoroquinolones
Granisetron
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination